Association of Fatal and Nonfatal Cardiovascular Outcomes With 24-Hour Mean Arterial Pressure
Jesus D. Melgarejo,Wen-Yi Yang,Lutgarde Thijs,Yan Li,Kei Asayama,Tine W. Hansen,Fang-Fei Wei,Masahiro Kikuya,Takayoshi Ohkubo,Eamon Dolan,Katarzyna Stolarz-Skrzypek,Qi-Fang Huang,Valérie Tikhonoff,Sofia Malyutina,Edoardo Casiglia,Lars Lind,Edgardo Sandoya,Jan Filipovský,Natasza Gilis-Malinowska,Krzysztof Narkiewicz,Kalina Kawecka-Jaszcz,José Boggia,Ji-Guang Wang,Yutaka Imai,Thomas Vanassche,Peter Verhamme,Stefan Janssens,Eoin O’Brien,Gladys E. Maestre,Jan A. Staessen,Zhen-Yu Zhang,J. Seidlerová,M. Tichá,H. Ibsen,J. Jeppesen,S. Rasmussen,C. Torp-Pedersen,A. Pizzioli,J. Hashimoto,H. Hoshi,R. Inoue,H. Metoki,T. Obara,H. Satoh,K. Totsune,A. Adamkiewicz-Piejko,M. Cwynar,J. Gąsowski,T. Grodzicki,W. Lubaszewski,A. Olszanecka,B. Wizner,W. Wojciechowska,J. Zyczkowska,Y. Nikitin,E. Pello,G. Simonova,M. Voevoda,B. Andrén,L. Berglund,K. Björklund-Bodegård,B. Zethelius,M. Bianchi,V. Moreira,C. Schettini,E. Schwedt,H. Senra
DOI: https://doi.org/10.1161/hypertensionaha.120.14929
IF: 9.8968
2020-12-11
Hypertension
Abstract:Download figure Download PowerPoint Major adverse cardiovascular events are closely associated with 24-hour blood pressure (BP). We determined outcome-driven thresholds for 24-hour mean arterial pressure (MAP), a BP index estimated by oscillometric devices. We assessed the association of major adverse cardiovascular events with 24-hour MAP, systolic BP (SBP), and diastolic BP (DBP) in a population-based cohort (n=11 596). Statistics included multivariable Cox regression and the generalized R 2 statistic to test model fit. Baseline office and 24-hour MAP averaged 97.4 and 90.4 mm Hg. Over 13.6 years (median), 2034 major adverse cardiovascular events occurred. Twenty-four-hour MAP levels of <90 (normotension, n=6183), 90 to <92 (elevated MAP, n=909), 92 to <96 (stage-1 hypertension, n=1544), and ≥96 (stage-2 hypertension, n=2960) mm Hg yielded equivalent 10-year major adverse cardiovascular events risks as office MAP categorized using 2017 American thresholds for office SBP and DBP. Compared with 24-hour MAP normotension, hazard ratios were 0.96 (95% CI, 0.80–1.16), 1.32 (1.15–1.51), and 1.77 (1.59–1.97), for elevated and stage-1 and stage-2 hypertensive MAP. On top of 24-hour MAP, higher 24-hour SBP increased, whereas higher 24-hour DBP attenuated risk ( P <0.001). Considering the 24-hour measurements, R 2 statistics were similar for SBP (1.34) and MAP (1.28), lower for DBP than for MAP (0.47), and reduced to null, if the base model included SBP and DBP; if the ambulatory BP indexes were dichotomized according to the 2017 American guideline and the proposed 92 mm Hg for MAP, the R 2 values were 0.71, 0.89, 0.32, and 0.10, respectively. In conclusion, the clinical application of 24-hour MAP thresholds in conjunction with SBP and DBP refines risk estimates.
peripheral vascular disease